# Genentech **Domain:** Biotechnology / Corporate History **Doc Type:** Company Node **Maturity:** Developed ## Definition **Genentech** is a biotechnology company co-founded in 1976 by Herbert Boyer and venture capitalist Robert Swanson to commercialize recombinant-DNA methods for producing biological products. ## Nexus Context Genentech represents the institutional transition from academic gene-cloning technique to biotechnology industry. [[articles/The Evolutionary Roots of Silicon Valley|The Evolutionary Roots of Silicon Valley]] places that transition beside the semiconductor lineage: both converted encoded systems into platforms for repeatable manufacturing. ## Governance Context Commercialization changes selection pressures. Research priorities become coupled to patents, capital, regulation and market demand. This can scale beneficial therapies while also concentrating control over biological infrastructure. ## Continuity Context For post-biological systems, Genentech is a reminder that a portable code becomes socially consequential only through production, custody and distribution. The operator of the interpreter may hold more power than the holder of the sequence. ## Sources / Provenance - Genentech corporate history: https://www.gene.com/about-us/history - Stanford Cohen–Boyer history: https://med.stanford.edu/sncohenlab/stan-cohen.html ## See Also [[wiki/Herbert Boyer|Herbert Boyer]], [[wiki/Recombinant DNA|Recombinant DNA]], [[wiki/Infrastructure as Power|Infrastructure as Power]], [[wiki/Continuity Economics|Continuity Economics]]